About Us

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.

JDD reaches around 13,760 dermatology healthcare professionals and has been recognized as the official partner of the Skin of Color Update (SOCU) and the ODAC Dermatology Aesthetic and Surgical (ODAC) conferences.

The extremely current and practical editorial content of JDD results in high readership and maximum exposure among the dermatology community.

Our Mission is Excellence through Peer Review: To educate physicians, optimize patient outcomes, and disseminate key scientific information.

JDD is published by SanovaWorks.

In the News

June 30, 2026 in JDD in the Media, Latest News, Nails, NP/PA Education

Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors

Nail Toxicities with FGFR Inhibitors — A JDD Systematic Review Worth Reading Have you read this article from the March 2026 issue of JDD? A systematic review covering reports through…
Read More
June 29, 2026 in Featured Articles, JDD in the Media, Latest News

JDD in the News: Distinguishing Malassezia Folliculitis from Acne Vulgaris

Dermatology Times highlighted three Journal of Drugs in Dermatology studies in recent articles, including an examination of “fungal acne.” In the study, “Malassezia Folliculitis Presentation, Diagnosis, and Treatment: A Review…
Read More
May 30, 2026 in Featured Articles, JDD in the Media, Latest News

JDD in the News: Topical Nonsteroidals for Chronic Hand Eczema

Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…
Read More
April 2, 2026 in Featured Articles, JDD in the Media, Latest News

Dermatology Roundup: NPF Clarifies Definition of Psoriasis Disease Severity

Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color The National Psoriasis Foundation (NPF) has a new position statement that clarifies the…
Read More
January 22, 2026 in Featured Articles, JDD in the Media, Latest News

JDD in the News: Skin and Hair Reactions from GLP-1 Agonists

Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Read More

Editorial Board

Founder
Perry Robins, MD

Editor-in-Chief
Deborah S. Sarnoff MD